Benzinga | Nov 23, 2021 09:22AM EST

Novavax To Participate In Evercore ISI's HealthCONx Conference Dec. 2 At 9:15 a.m. EST

Novavax, Inc. (NASDAQ:NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it will participate in Evercore ISI's 4th Annual HealthCONx Virtual Conference. Novavax' recombinant nanoparticle protein-based COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion.

Conference Details: Fireside Chat

Date: Thursday, December 2, 2021

Time: 9:15 ? 9:35 a.m. Eastern Time (ET)

Moderator: Josh Schimmer

Novavax Gregory M. Glenn, M.D., President, Research and Development andparticipants: John J. Trizzino, Executive Vice President, Chief Commercial Officer and Chief Business Officer

Conference

Event: Investor meetings

Date: Thursday, December 2, 2021



A replay of the recorded fireside session will be available through the events page of the Company's website at ir.novavax.com for 90 days.